Viewing Study NCT03052569


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-03-23 @ 5:45 PM
Study NCT ID: NCT03052569
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2019-04-26
First Post: 2017-02-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to RXDX-105 for Cancers With RET Alterations
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module